Lucius Pharmaceutical (Laos) Co., Ltd. operates complete, advanced pharmaceutical manufacturing facilities that strictly comply with EU pharmaceutical standards and are capable of producing internationally standardized medical products. Lucius’s facilities can manufacture the following categories of drugs:

● Anti-tumor drugs;
● Antiviral drugs;
● Conventional liquid drugs;
● Cephalosporin drugs.

Lucius can manufacture the following dosage forms:

● Oral formulations: tablets, capsules, dry syrups, liquid preparations (syrups and suspensions);
● Parenteral formulations: lyophilized products (conventional and anti-tumor), prefilled syringes, large-volume injections, small-volume injections.

Why Lucius is an ideal global contract manufacturing partner

Lucius possesses advanced pharmaceutical technology and can manufacture OEM products for customers worldwide to minimize overall production costs, for the following reasons:

● Manufacturing facilities for anti-tumor and conventional drugs that comply with WHO GMP standards;
● Capability to produce high-tech pharmaceutical products;
● Under WTO agreements, Lucius may produce any patented medicine;
● A strong R&D team and the ability to develop new products;
● Labor costs far lower than in most other countries.

Lucius’s production facilities and operations strictly comply with the good manufacturing practices (GMP) of the World Health Organization (WHO), and provide diversified product-processing technologies including solid, semi-solid and liquid pharmaceutical forms, as well as support for packaging, process optimization and formulation development. Through contract manufacturing, customers can substantially reduce costs.